Theravance Biopharma, Inc.

CHARLES SCHWAB INVESTMENT MANAGEMENT INC TBPH

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

313,294

Value ($000)

5,862

Weight

0.0%

2014 Q2 - 2025 Q4 (26 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	5,862	0.0%	313,294	12/31/2025
2025 Q3	11/10/2025	4,674	0.0%	320,144	9/30/2025
2025 Q2	8/12/2025	3,352	0.0%	303,887	6/30/2025
2025 Q1	9/15/2025	2,569	0.0%	287,716	3/31/2025
2024 Q4	2/6/2025	2,766	0.0%	293,936	12/31/2024
2024 Q3	11/12/2024	2,353	0.0%	291,876	9/30/2024
2024 Q2	8/12/2024	2,470	0.0%	291,266	6/30/2024
2024 Q1	5/9/2024	2,785	0.0%	310,501	3/31/2024
2023 Q4	2/6/2024	3,529	0.0%	314,011	12/31/2023
2023 Q3	11/8/2023	2,832	0.0%	328,177	9/30/2023
2023 Q2	8/10/2023	4,176	0.0%	403,459	6/30/2023
2023 Q1	5/12/2023	5,239	0.0%	482,872	3/31/2023
2022 Q4	2/13/2023	5,794	0.0%	516,388	12/31/2022
2022 Q3	11/14/2022	5,323	0.0%	524,916	9/30/2022
2022 Q2	8/15/2022	4,562	0.0%	503,477	6/30/2022
2022 Q1	5/13/2022	3,850	0.0%	402,640	3/31/2022
2021 Q4	2/11/2022	4,316	0.0%	390,545	12/31/2021
2021 Q3	11/16/2021	2,604	0.0%	351,793	9/30/2021
2021 Q2	8/16/2021	5,178	0.0%	356,544	6/30/2021
2021 Q1	5/17/2021	6,807	0.0%	333,484	3/31/2021
2020 Q4	2/16/2021	5,750	0.0%	323,578	12/31/2020
2020 Q3	11/13/2020	4,637	0.0%	313,564	9/30/2020
2020 Q2	8/20/2020	6,596	0.0%	314,210	6/30/2020
2020 Q1	5/15/2020	6,924	0.0%	299,576	3/31/2020
2019 Q4	2/7/2020	6,942	0.0%	268,100	12/31/2019
2014 Q2	7/30/2014	1,926	0.0%	60,385	6/30/2014